KAIST researchers discover molecular switch that can reverse cancer cell transformation at transition point
By
ecancer
Hand-rolled, kettle-boiled, baked to perfection. Worth every minute at the bakery.
Summary
KAIST Professor Kwang-Hyun Cho's research team has discovered a molecular switch in the genetic network that can reverse cancerous transformation at the critical moment when normal cells transition into cancer cells. This breakthrough builds on their earlier work developing cancer reversal treatment technology that changes cancer cells back to a state resembling normal cells, rather than killing them. The finding reveals that the molecular switch is hidden within the genetic network and can induce cancer reversal specifically during the transition phase.
Key quotes
· 2 pulledProfessor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology for cancer reversal treatment that does not kill cancer cells but only changes their characteristics to reverse them to a state similar to normal cells.
They have succeeded in revealing for the first time that a molecular switch that can induce cancer reversal at the moment when normal cells change into cancer cells is hidden in the genetic network.
You might also wanna read
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
The billion-dollar bet on reversing aging: from body as machine to life as editable information
This opinion article by Álvaro Machado Dias explores the shift in scientific metaphors for understanding the human body and aging. It traces
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha

Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
